These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 15747588)

  • 1. Comparison between two partial likelihood approaches for the competing risks model with missing cause of failure.
    Lu K; Tsiatis AA
    Lifetime Data Anal; 2005 Mar; 11(1):29-40. PubMed ID: 15747588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple imputation methods for estimating regression coefficients in the competing risks model with missing cause of failure.
    Lu K; Tsiatis AA
    Biometrics; 2001 Dec; 57(4):1191-7. PubMed ID: 11764260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vertical modelling: Analysis of competing risks data with missing causes of failure.
    Nicolaie MA; van Houwelingen HC; Putter H
    Stat Methods Med Res; 2015 Dec; 24(6):891-908. PubMed ID: 22179822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Semiparametric regression and risk prediction with competing risks data under missing cause of failure.
    Bakoyannis G; Zhang Y; Yiannoutsos CT
    Lifetime Data Anal; 2020 Oct; 26(4):659-684. PubMed ID: 31982977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A profile conditional likelihood approach for the semiparametric transformation regression model with missing covariates.
    Chen HY; Little RJ
    Lifetime Data Anal; 2001 Sep; 7(3):207-24. PubMed ID: 11677827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Semiparametric marginal regression for clustered competing risks data with missing cause of failure.
    Zhou W; Bakoyannis G; Zhang Y; Yiannoutsos CT
    Biostatistics; 2023 Jul; 24(3):795-810. PubMed ID: 35411923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Missing cause of death information in the analysis of survival data.
    Andersen J; Goetghebeur E; Ryan L
    Stat Med; 1996 Oct; 15(20):2191-201. PubMed ID: 8910963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Semiparametric estimation in the proportional hazard model accounting for a misclassified cause of failure.
    Ha J; Tsodikov A
    Biometrics; 2015 Dec; 71(4):941-9. PubMed ID: 26102346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new approach to regression analysis of censored competing-risks data.
    Jin Y; Lai TL
    Lifetime Data Anal; 2017 Oct; 23(4):605-625. PubMed ID: 27502000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Direct likelihood inference and sensitivity analysis for competing risks regression with missing causes of failure.
    Moreno-Betancur M; Rey G; Latouche A
    Biometrics; 2015 Jun; 71(2):498-507. PubMed ID: 25761785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pairwise likelihood augmented Cox estimator for left-truncated data.
    Wu F; Kim S; Qin J; Saran R; Li Y
    Biometrics; 2018 Mar; 74(1):100-108. PubMed ID: 28853158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A semiparametric estimate of treatment effects with censored data.
    Xu R; Harrington DP
    Biometrics; 2001 Sep; 57(3):875-85. PubMed ID: 11550940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frailty modeling for clustered competing risks data with missing cause of failure.
    Lee M; Ha ID; Lee Y
    Stat Methods Med Res; 2017 Feb; 26(1):356-373. PubMed ID: 25125452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Additive hazards model with auxiliary subgroup survival information.
    He J; Li H; Zhang S; Duan X
    Lifetime Data Anal; 2019 Jan; 25(1):128-149. PubMed ID: 29470696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of treatment effects based on possibly misspecified Cox regression.
    Hattori S; Henmi M
    Lifetime Data Anal; 2012 Oct; 18(4):408-33. PubMed ID: 22527680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the Breslow estimator.
    Lin DY
    Lifetime Data Anal; 2007 Dec; 13(4):471-80. PubMed ID: 17768681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing treatment effects with surrogate survival outcomes using an internal validation subsample.
    Zee J; Xie SX;
    Clin Trials; 2015 Aug; 12(4):333-41. PubMed ID: 25976869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the time-varying Cox model for the cause-specific hazard functions with missing causes.
    Heng F; Sun Y; Hyun S; Gilbert PB
    Lifetime Data Anal; 2020 Oct; 26(4):731-760. PubMed ID: 32274677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The competing risks Cox model with auxiliary case covariates under weaker missing-at-random cause of failure.
    Nevo D; Nishihara R; Ogino S; Wang M
    Lifetime Data Anal; 2018 Jul; 24(3):425-442. PubMed ID: 28779227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cox model with interval-censored covariate in cohort studies.
    Ahn S; Lim J; Paik MC; Sacco RL; Elkind MS
    Biom J; 2018 Jul; 60(4):797-814. PubMed ID: 29775990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.